Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)Adarsh Bhimraj, Yngve Falck–Ytter, Rebecca L. Morgan et al.|Clinical Infectious Diseases|2020Cited by 1.1k
A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADERebecca L. Morgan, Holger J. Schünemann, Kristina A. Thayer et al.|Environment International|2018Cited by 247
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Yngve Falck–Ytter, Rebecca L. Morgan et al.|Clinical Infectious Diseases|2022Cited by 201
Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the ‘target experiment’ concept in studies of exposures: Rationale and preliminary instrument developmentRebecca L. Morgan, Holger J. Schünemann, Kristina A. Thayer et al.|Environment International|2018Cited by 104
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide ConsensusSanjay Ramakrishnan, Mona Bafadhel, Rebecca L. Morgan et al.|International Journal of COPD|2021Cited by 28